Skip to main content
. 2018 Nov 8;10:80. doi: 10.1186/s13098-018-0384-8

Table 3.

Change in changes in metabolic criteria across a cross the study groups

Variables Groups (n = 141) P valueg
Vit D (n = 24)a Vita D + PA (n = 21)b Vit C (n = 26)c Vit C + PA (n = 23)d Placebo (n = 25)e Placebo + PA (n = 22)f
Weight (kg) .4 ± 1.3 − 2.8 ± 7.9 − 1.6 ± 2.2 − 1.8 ± 4.3 − .03 ± 1.3 − 1.2 ± 1 .058
BMI (kg/m2) .16 ± .5 − 1.3 ± 3.5 − .6 ± .8 − .6 ± 1.3 − .01 ± .5 − .5 ± .4 .031
WC (cm) − .04 ± 2.1 − 1.2 ± 2.2 − 1.2 ± 2.3 − 4.2 ± 6.1 − 1.4 ± 3.6 − 3.6 ± 1.4 .001
FPG (mg/dL) − 10.2 ± 15.9 − 8.3 ± 16.2 − 1.7 ± 11 − 3.3 ± 14.3 − 2.6 ± 19.7 − 7.4 ± 14.6 .325
SBP (mmHg) − 5.8 ± 7.1 − 2.9 ± 9.7 − .1 ± 8 44.1 ± 251.1 1 ± 8.2 − 5.7 ± 7.9 .552
DBP (mmHg) 1 ± 6.9 − 1.9 ± 7.7 .6 ± 7.4 .2 ± 8.2 1.6 ± 8.7 − 2.3 ± 6.3 .434
TC (mg/dL) − 13 ± 42.3 − 13 ± 16.7 5.4 ± 24.9 − 3.1 ± 22.4 10.9 ± 32.8 − 9.3 ± 17 .012
TG (mg/dL) 4.6 ± 32.9 − 6.4 ± 29.4 − 22.3 ± 31.2 − 25 ± 68.8 11.2 ± 29.8 − 6.1 ± 18.8 .006
LDL-C (mg/dL) − 13.7 ± 43.8 − 11.3 ± 19.8 9.8 ± 24.8 − 1 ± 27.8 8.3 ± 30.9 − 7.7 ± 17.9 .017
HDL-C (mg/dL) − 1.3 ± 12.9 − 1.9 ± 13.4 .1 ± 11.1 14.3 ± 20 1.7 ± 7.2 − 1.9 ± 13.9 .001
Vit D (ng/mL) 12.4 ± 4.3 18.6 ± 6.8 .5 ± 1.3 7.9 ± 2.8 .001
Vit C (ng/mL) .5 ± .5 .9 ± .4 − .07 ± .5 .1 ± .5 .001

Data are mean ± standard deviation (SD)

PA, physical activity; BMI, body mass index; WC, waist circumferences; FPG, fasting blood sugar; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol

aReceiving 2000 IU vitamin D per day

bReceiving 2000 IU vitamin D per day plus 30 min endurance physical activity

cReceiving 500 mg vitamin C per day

dReceiving 500 mg vitamin C per day plus 30 min endurance physical activity

eReceiving one placebo per day

fReceiving one placebo per day plus 30 min endurance physical activity

gObtained from ANOVA or Chi square test, where appropriate